down arrow

Vivo Bio Tech

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE380K01017
  • NSEID:
  • BSEID: 511509
INR
34.55
-0.34 (-0.97%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 2.89 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

34.1635.89

52 Week

31.2056.90
Valuation
Technical
Day's Volume

CASH

2.89 k (-58.44%) Volume

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

41.57%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -3.37% CAGR growth in Net Sales over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.97
  • The company has been able to generate a Return on Equity (avg) of 7.95% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Mildly Bearish range

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 59 Cr (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.95

stock-summary
Return on Equity

12.47%

stock-summary
Price to Book

0.98

Revenue and Profits (1 Year):
Net Sales:
12 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-7.27%
0%
-7.27%
1 Year
-23.09%
0%
-23.09%
2 Years
42.47%
0%
42.47%
3 Years
-30.9%
0%
-30.9%
4 Years
-31.52%
0%
-31.52%
5 Years
11.27%
0%
11.27%

Vivo Bio Tech for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.37%
EBIT Growth (5y)
6.44%
EBIT to Interest (avg)
1.97
Debt to EBITDA (avg)
2.63
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.57
Tax Ratio
22.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.64%
ROE (avg)
7.95%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
33
Price to Book Value
0.98
EV to EBIT
9.89
EV to EBITDA
5.53
EV to Capital Employed
0.99
EV to Sales
2.50
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
10.73%
ROE (Latest)
12.47%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Cryptologic Systems Private Limited (7.97%)

Highest Public shareholder

Elite Class Asset Holdings Ltd (7.71%)

Individual Investors Holdings

33.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.41% vs 18.85% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -84.32% vs 2,976.47% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.21",
          "val2": "12.04",
          "chgp": "1.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.54",
          "val2": "5.59",
          "chgp": "-0.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.84",
          "val2": "2.06",
          "chgp": "-10.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.82",
          "val2": "5.23",
          "chgp": "-84.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.37%",
          "val2": "46.43%",
          "chgp": "-1.06%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.17",
          "val2": "20.84",
          "chgp": "6.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.95",
          "val2": "9.34",
          "chgp": "6.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.99",
          "val2": "4.04",
          "chgp": "-1.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.40",
          "val2": "0.47",
          "chgp": "1,048.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.88%",
          "val2": "44.82%",
          "chgp": "0.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.05% vs -10.11% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 247.49% vs 203.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.38",
          "val2": "33.69",
          "chgp": "2.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.49",
          "val2": "15.72",
          "chgp": "-1.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.83",
          "val2": "6.26",
          "chgp": "-6.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.22",
          "val2": "1.79",
          "chgp": "247.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "45.06%",
          "val2": "46.66%",
          "chgp": "-1.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -12.98% vs 1.63% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -4.53% vs 20.45% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.45",
          "val2": "52.23",
          "chgp": "-12.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.09",
          "val2": "21.51",
          "chgp": "-1.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.78",
          "val2": "7.65",
          "chgp": "1.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.53",
          "val2": "2.65",
          "chgp": "-4.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "46.40%",
          "val2": "41.18%",
          "chgp": "5.22%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
12.21
12.04
1.41%
Operating Profit (PBDIT) excl Other Income
5.54
5.59
-0.89%
Interest
1.84
2.06
-10.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.82
5.23
-84.32%
Operating Profit Margin (Excl OI)
45.37%
46.43%
-1.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.41% vs 18.85% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -84.32% vs 2,976.47% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
22.17
20.84
6.38%
Operating Profit (PBDIT) excl Other Income
9.95
9.34
6.53%
Interest
3.99
4.04
-1.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.40
0.47
1,048.94%
Operating Profit Margin (Excl OI)
44.88%
44.82%
0.06%
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
34.38
33.69
2.05%
Operating Profit (PBDIT) excl Other Income
15.49
15.72
-1.46%
Interest
5.83
6.26
-6.87%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.22
1.79
247.49%
Operating Profit Margin (Excl OI)
45.06%
46.66%
-1.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.05% vs -10.11% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 247.49% vs 203.39% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
45.45
52.23
-12.98%
Operating Profit (PBDIT) excl Other Income
21.09
21.51
-1.95%
Interest
7.78
7.65
1.70%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.53
2.65
-4.53%
Operating Profit Margin (Excl OI)
46.40%
41.18%
5.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -12.98% vs 1.63% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -4.53% vs 20.45% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Vivo Bio Tech Ltd. stock-summary
stock-summary
Vivo Bio Tech Ltd.
Micro Cap
Pharmaceuticals & Drugs
Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.
Company Coordinates stock-summary
Company Details
Survey #349/A Pregnapur Vlge , Gajel Telangana : 502311
stock-summary
Tel:
stock-summary
http://www.vivobio.com
stock-summary
investors@vivobio.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."